Cargando…

Future of the drug label: Perspectives from a multistakeholder dialogue

Regulating drugs does not end when market access has been granted. Monitoring drugs over the life cycle has become state of the art, inherent to evolving legislation and societal need. Here, we explore how the drug label could move along in a changing playing‐field and become a sustainable label for...

Descripción completa

Detalles Bibliográficos
Autores principales: Gispen‐de Wied, Christine C., Weemers, Just, Boon, Wouter, Mol, Peter G.M., Stolk, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783599/
https://www.ncbi.nlm.nih.gov/pubmed/31317570
http://dx.doi.org/10.1111/bcp.14070

Ejemplares similares